New shot for rare lung disease could replace IV drips
Disease control
Not yet recruiting
This study tests a new under-the-skin injection of Alpha1-Proteinase Inhibitor for adults with Alpha-1 Antitrypsin Deficiency, a genetic condition that can damage lungs and liver. About 40 participants will receive either the new weekly shot or the standard weekly IV dose to comp…
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated May 17, 2026 15:08 UTC